Smallwood N, Pascoe A, Buchan C, Wong A, Currow D, Le B
Ther Adv Respir Dis. 2025; 19:17534666251314722.
PMID: 40071312
PMC: 11898029.
DOI: 10.1177/17534666251314722.
Ahmadi Z, Smallwood N, Russell A, Saggu R, Romero L, Holland A
Eur Respir Rev. 2025; 34(175).
PMID: 40044186
PMC: 11880903.
DOI: 10.1183/16000617.0025-2024.
Cajanding R
Nurs Crit Care. 2021; 27(2):282-285.
PMID: 34476873
PMC: 8661992.
DOI: 10.1111/nicc.12709.
Kim Y, Kim H, Park J, Hong J, Kim J, Min K
Korean J Intern Med. 2021; 37(1):119-126.
PMID: 34412177
PMC: 8747924.
DOI: 10.3904/kjim.2020.470.
Kakavas S, Kotsiou O, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K
NPJ Prim Care Respir Med. 2021; 31(1):23.
PMID: 33963190
PMC: 8105397.
DOI: 10.1038/s41533-021-00236-w.
Exercise response to oxygen supplementation is not associated with survival in hypoxemic patients with obstructive lung disease.
Sadaka A, Montgomery A, Mourad S, Polkey M, Hopkinson N
Int J Chron Obstruct Pulmon Dis. 2018; 13:1607-1612.
PMID: 29844666
PMC: 5963480.
DOI: 10.2147/COPD.S163119.
Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer.
Newsome B, McDonnell K, Hucks J, Estrada R
Clin J Oncol Nurs. 2018; 22(2):184-192.
PMID: 29547609
PMC: 6613547.
DOI: 10.1188/18.CJON.184-192.
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.
Di Marco F, Sotgiu G, Santus P, ODonnell D, Beeh K, Dore S
Respir Res. 2018; 19(1):18.
PMID: 29368604
PMC: 5784692.
DOI: 10.1186/s12931-018-0721-3.
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study....
Currow D, Watts G, Johnson M, McDonald C, Miners J, Somogyi A
BMJ Open. 2017; 7(7):e018100.
PMID: 28716797
PMC: 5726102.
DOI: 10.1136/bmjopen-2017-018100.
Care at the Very End-of-Life: Dying Cancer Patients and Their Chosen Family's Needs.
Clark K
Cancers (Basel). 2017; 9(2).
PMID: 28125017
PMC: 5332934.
DOI: 10.3390/cancers9020011.
Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people....
Watts G, Clark K, Agar M, Davidson P, McDonald C, Lam L
BMJ Open. 2016; 6(11):e013177.
PMID: 27899400
PMC: 5168508.
DOI: 10.1136/bmjopen-2016-013177.
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.
Ekstrom M, Ahmadi Z, Bornefalk-Hermansson A, Abernethy A, Currow D
Cochrane Database Syst Rev. 2016; 11:CD006429.
PMID: 27886372
PMC: 6464154.
DOI: 10.1002/14651858.CD006429.pub3.
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
Albert R, Au D, Blackford A, Casaburi R, Cooper Jr J, Criner G
N Engl J Med. 2016; 375(17):1617-1627.
PMID: 27783918
PMC: 5216457.
DOI: 10.1056/NEJMoa1604344.
Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease.
Ahmadi Z, Sundh J, Bornefalk-Hermansson A, Ekstrom M
PLoS One. 2016; 11(9):e0163293.
PMID: 27649490
PMC: 5029935.
DOI: 10.1371/journal.pone.0163293.
Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.
ODonnell D, Elbehairy A, Faisal A, Webb K, Neder J, Mahler D
Eur Respir Rev. 2016; 25(141):333-47.
PMID: 27581832
PMC: 9487205.
DOI: 10.1183/16000617.0054-2016.